Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Renal Transplant Recipients (OPTI-TREX)
Condition: Patients Included Are Pediatric Renal Transplant Recipients With an Indication for Enoxaparin Treatment in the First Post-transplant Week Interventions: Drug: Bayesian based dose adjustment of enoxaparin; Drug: Usual dose adjustment of enoxaparin Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials